Ben Hargreaves examines why a research project in the UK could provide key insights to develop treatments against many of the most prominent diseases impacting society.
Despite pharmaceutical breakthroughs in multiple sclerosis (MS), a lot still needs to be done to improve care for patients with all forms of the disease.
Award-winning patient advocate Trishna Bharadia speaks to Marco Ricci about the challenges facing people with multiple sclerosis (MS) and what needs to be done to improve management of this unp
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio